Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00311168 · ClinicalTrials.gov registry record · NA
Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
NCT00311168 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 135 participants.
The verdict
NCT00311168, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of the VIP™ feature (available in dual chamber Victory® devices) to reduce unnecessary RV pacing, and to determine if patients with implanted SJM pacemakers will benefit by using VIP™ rather than only a programmed AV/PV delay.
Interventions
- DEVICE Intervention/treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00311168
The ClinicalTrials.gov registry entry for NCT00311168 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intervention/treatment is the first listed.
NCT00311168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00311168 about?
NCT00311168 is a clinical study titled "Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)". The purpose of this study is to evaluate the efficacy of the VIP™ feature (available in dual chamber Victory® devices) to reduce unnecessary RV pacing, and to determine if patients with implanted SJM pacemakers will benefit by using VIP™ rather than only a programmed AV/PV delay.
What is the current status of trial NCT00311168?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2006-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00311168?
The interventions under investigation include: Intervention/treatment (DEVICE).
Who is sponsoring clinical trial NCT00311168?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.